Julian Hosp, an Austrian doctor turned crypto entrepreneur, exited most of his crypto holdings in early 2025, shorted Bitcoin, and shifted his investments into the Nasdaq-100 ETF (QQQ). Once a prominent Bitcoin advocate and co-founder of projects like TenX and Cake DeFi, Hosp now calls crypto "pure speculation" and warns of further Bitcoin declines. His pivot has sparked controversy, with critics accusing him of hypocrisy and self-interest, while supporters argue he is simply adapting his strategy based on new information. Hosp remains a vocal Bitcoin skeptic and influential figure in the German-speaking crypto community.
The global reactive hot melt adhesives market is projected to grow from $2.02 billion in 2025 to $4.29 billion by 2035, at a CAGR of 7.72%. Growth is driven by regulations limiting solvent-based adhesives, increased use of polyurethane adhesives in a...
The global automotive microcontrollers market is projected to grow from USD 15.49 billion in 2025 to USD 34.31 billion by 2035, at a CAGR of 8.28%. Growth is fueled by increasing adoption of advanced driver-assistance systems (ADAS), vehicle electrif...
CHARBONE Corporation has increased its helium delivery fleet from one to five units to meet rising demand caused by global helium supply disruptions, notably from Qatar. This expansion supports North American customers in sectors like semiconductors ...
Citi has started coverage of Hikma Pharmaceuticals with a 'buy' rating and a £17 price target, highlighting the company's strategic shift towards differentiated products and US manufacturing investments. The broker sees a 14% potential share price re...
Xenon Pharmaceuticals is evolving into a late-stage, cash-rich neuroscience company with a validated Kv7 potassium channel platform. Its lead drug candidate, azetukalner, has shown strong effectiveness in treating refractory focal onset seizures and ...
